Response to BRAF/MEK Inhibition After Progression With BRAF Inhibition in a Patient With Anaplastic Pleomorphic Xanthoastrocytoma

The Neurologist
Faiz HussainRimas V Lukas

Abstract

Pleomorphic xanthoastrocytoma (PXA) is a rare primary central nervous system tumor which frequently harbors mutations in BRAF. Anaplastic PXA follow a more aggressive course than their nonanaplastic counterparts. We present the case of an anaplastic PXA initially treated with the BRAF inhibitor vemurafenib. After progression of disease the MEK inhibitor trametinib was added to the regimen leading to radiographic improvement. The rationale for combined BRAF and MEK inhibition in PXA is reviewed.

References

Dec 4, 2001·Biology of the Cell·C Peyssonnaux, A Eychène
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Aug 6, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eudocia Q LeeSandro Santagata
Oct 17, 2014·Brain Pathology·Cristiane M IdaCaterina Giannini
Jun 22, 2016·Expert Opinion on Drug Discovery·Alex Kim, Mark S Cohen
Jul 19, 2016·Annals of Translational Medicine·José Luís ManzanoAnna Martínez-Cardús
Oct 27, 2016·CNS Oncology·Nicholas F BrownPaul Mulholland
Dec 14, 2016·World Neurosurgery·Christopher S HongJames Bradley Elder
Feb 27, 2017·Neurology·Denis MiglioriniPierre-Yves Dietrich
Oct 7, 2017·CNS Oncology·Nicholas F BrownPaul Mulholland

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection

Clinical Trials Mentioned

NCT02465060

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.